Biosimilar Applicants Must Provide Notice of Commercial Launch What You Need To Know Case Background In an opinion released today in Amgen v. Apotex, the Federal Circuit held biosimilar applicants…

The Defend Trade Secrets Act signed into law in May filled a gap in existing law and allows companies to protect their trade secrets across state lines and outside of…

Knobbe Martens Olson & Bear LLP has once again been recognized by The Legal 500, an annually published directory of the top legal service providers worldwide, for its outstanding legal work in…

The PTAB Does Not Have to Consider New Arguments Raised in IPR Reply Briefs In Intelligent Bio-Systems, Inc. v. Illumina Cambridge Ltd., Appeal No. 2015-1693, the Federal Circuit upheld a…

Coca-Cola has Acquired Secondary Meaning in ZERO for Colas In an opposition proceeding before the TTAB, Royal Crown (RC) and Dr. Pepper/Seven Up sought to prevent registration of seventeen applications…

Knobbe Martens Olson & Bear LLP, one of the leading intellectual property law firms in the United States, was recently recognized at the 2016 International Legal Alliance Summit & Awards…

Partner Cheryl Burgess was published in Electronic Engineering Times (EE Times) with an article titled “Patent Infringement Cases Just Got Easier.” In a decision with significant impact for engineers, the…

Knobbe Martens Olson & Bear LLP has been recognized as one of the top 20 law firms globally for intellectual property in the 2016 “Who’s Who Legal 100.” To compile…

PTAB’s Institution Decision Remains Largely Unreviewable – What You Need To Know Summary In its first case addressing an Inter Partes Review (“IPR”), the Supreme Court’s In re Cuozzodecision unanimously upheld the…

The value of a company’s patent portfolio can be increased significantly if the portfolio strategically uses continuing applications (i.e., continuation, divisional, and continuation-in-part applications) to extract valuable protection from disclosures…